DHRS11

Across TCGA pan-cancer cohorts, DHRS11 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated DHRS11 data layer compared with 26 for mass-spec protein and 4 for mass-spec protein.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher DHRS11 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated DHRS11 expression acts as an unfavorable survival marker.

HNSC and SKCM are the cancer types where DHRS11 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Median	All	0.084	0.752	<.001	54	view →
SKCM	DFS	Median	All	0.228	0.622	.008	14	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

DHRS11–HNSC (OS)

Open the HNSC breakdown →